{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:28:25Z","timestamp":1780086505091,"version":"3.54.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6-7","license":[{"start":{"date-parts":[[1997,6,1]],"date-time":"1997-06-01T00:00:00Z","timestamp":865123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1997,6]]},"DOI":"10.1007\/bf01291879","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T15:13:33Z","timestamp":1111677213000},"page":"605-614","source":"Crossref","is-referenced-by-count":8,"title":["Potentiation of DOI-induced forward locomotion in rats by (?)-pindolol pretreatment"],"prefix":"10.1007","volume":"104","author":[{"given":"P.","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ahlenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-0773.1995.tb00122.x","volume":"76","author":"S Ahlenius","year":"1995","unstructured":"Ahlenius S, Salmi P (1995) Antagonism of reserpine-induced suppression of spontaneous motor activity by stimulation of 5-HT1A receptors in rats. Pharmacol Toxicol 76: 149?156","journal-title":"Pharmacol Toxicol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0014-2999(94)90119-8","volume":"261","author":"A Albinsson","year":"1994","unstructured":"Albinsson A, Bj\ufffdrk A, Svartengren J, Klint T, Andersson G (1994) Preclinical pharmacology of FG5893: a potential anxiolytic drug with high affinity for both 5-HT1A and 5-HT2A receptors. Eur J Pharmacol 261: 285?294","journal-title":"Eur J Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/215852b0","volume":"215","author":"G Bartholini","year":"1967","unstructured":"Bartholini G, Burkard WP, Pletscher A, Bates HM (1967) Increase of cerebral catecholamines caused by 3,4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase. Nature 215: 852?853","journal-title":"Nature"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0091-3057(90)90098-3","volume":"36","author":"NA Darmani","year":"1990","unstructured":"Darmani NA, Martin BR, Pandey U, Glennon RA (1990) Do functional relationship exist between 5-HT1A and 5-HT2 receptors? Pharmacol Biochem Behav 36: 901?906","journal-title":"Pharmacol Biochem Behav"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0160-5402(91)90002-M","volume":"25","author":"E Ericson","year":"1991","unstructured":"Ericson E, Samuelsson J, Ahlenius S (1991) Photocell measurements of rat motor activity. J Pharmacol Meth 25: 111?122","journal-title":"J Pharmacol Meth"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.2042-7158.1971.tb08673.x","volume":"23","author":"K Fuxe","year":"1971","unstructured":"Fuxe K, Butcher LL, Engel J (1971)Dl-5-Hydroxytryptophan-induced changes in central monoamine neurons after peripheral decarboxylase inhibition. J Pharm Pharmacol 23: 420?424","journal-title":"J Pharm Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0149-7634(05)80158-7","volume":"14","author":"RA Glennon","year":"1990","unstructured":"Glennon RA (1990) Serotonin receptors: clinical implications. Neurosci Biobehav Rev 14: 35?47","journal-title":"Neurosci Biobehav Rev"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/0028-3908(84)90096-0","volume":"23","author":"AR Green","year":"1984","unstructured":"Green AR (1984) 5-HT-mediated behavior. Neuropharmacol 23: 1521?1528","journal-title":"Neuropharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0014-2999(95)00666-4","volume":"295","author":"V Hillegaart","year":"1996","unstructured":"Hillegaart V, Estival A, Ahlenius S (1996) Evidence for specific involvement of 5-HT1A and 5-HT2A\/C receptors in the expression of patterns of spontaneous motor activity of the rat. Eur J Pharmacol 295: 155?161","journal-title":"Eur J Pharmacol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/0028-3908(85)90207-2","volume":"24","author":"S Hjorth","year":"1985","unstructured":"Hjorth S, Carlsson A (1985) (?)-Pindolol stereospecifically inhibits rat brain serotonin (5-HT) synthesis. Neuropharmacol 24: 1143?1146","journal-title":"Neuropharmacol"},{"key":"CR11","first-page":"199","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"BB Hoffman","year":"1996","unstructured":"Hoffman BB, Lefkowitz RJ (1996) Catecholamines, sympathomimetic drugs, and adren-ergic receptor antagonists. In: Hardman JG, Limbird LE (eds) Goodman and Gilman's the pharmacological basis of therapeutics. McGraw-Hill, New York, pp 199?248"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0014-2999(85)90658-2","volume":"118","author":"D Hoyer","year":"1985","unstructured":"Hoyer D, Engel G, Kalkman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (?)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol 118: 13?23","journal-title":"Eur J Pharmacol"},{"key":"CR13","first-page":"157","volume":"46","author":"D Hoyer","year":"1994","unstructured":"Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena R, Humphrey PPA (1994) VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46: 157?203","journal-title":"Pharmacol Rev"},{"key":"CR14","first-page":"600","volume":"27","author":"JE Leysen","year":"1985","unstructured":"Leysen JE, Gommeren W, van Gompel P, Wynants J, Janssen PFM, Laduron PM (1985) Receptor-binding properties in vitro and in vivo of ritanserin. A very potent and long acting serotonin-S2 antagonist. Mol Pharmacol 27: 600?611","journal-title":"Mol Pharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1021\/jm00203a008","volume":"21","author":"UH Lindberg","year":"1978","unstructured":"Lindberg UH, Thorberg S-O, Bengtsson S, Renyi AL, Ross SB, \ufffdgren S-O (1978) Inhibitors of neuronal monoamine uptake. Selective inhibition of 5-hydroxytryptamine uptake by an amino acid ester of phenethyl alcohols. J Med Chem 21: 448?456","journal-title":"J Med Chem"},{"key":"CR16","first-page":"246","volume":"16","author":"JJ Lucas","year":"1995","unstructured":"Lucas JJ, Hen R (1995) New players in the 5-HT receptor field: genes and knockouts. TiPS 16: 246?252","journal-title":"TiPS"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0006-8993(72)90478-7","volume":"45","author":"LK Ng","year":"1972","unstructured":"Ng LK, Chase TN, Colburn RW, Kopin IJ (1972) Release of [3H]dopamine by 1-5-hydroxytryptophan. Brain Res 45: 499?505","journal-title":"Brain Res"},{"issue":"Suppl 4","key":"CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004850-199609004-00001","volume":"11","author":"L Romero","year":"1996","unstructured":"Romero L, Bel N, Casanovas JM, Artigas F (1996) Two actions are better than one: avoiding self-inhibition of serotonergic neurones enhances the effects of serotonin uptake inhibitors. Int Clin Psychopharmacol 11 [Suppl 4]: 1?8","journal-title":"Int Clin Psychopharmacol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-2999(84)90333-9","volume":"102","author":"M Shannon","year":"1984","unstructured":"Shannon M, Battaglia G, Glennon RA, Titeler M (1984) 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxy-phenyl)-2-aminopropane (2,5-DMA). Eur J Pharmacol 102: 23?29","journal-title":"Eur J Pharmacol"},{"key":"CR20","first-page":"297","volume":"85","author":"T Sharp","year":"1992","unstructured":"Sharp T, Hjorth S (1992) In vivo neurochemical studies of 5-HT1A autoreceptor function. Adv Biosci 85: 297?323","journal-title":"Adv Biosci"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0006-8993(90)90593-Z","volume":"515","author":"JA Stamford","year":"1990","unstructured":"Stamford JA, Kruk ZL, Millar J (1990) Striatal dopamine terminals release serotonin after 5-HTP pretreatment: in vivo voltammetric data. Brain Res 515: 173?180","journal-title":"Brain Res"},{"key":"CR22","first-page":"403","volume":"6","author":"MD Tricklebank","year":"1985","unstructured":"Tricklebank MD (1985) The behavioral response to 5-HT receptor agonists and subtypes of the central 5-HT receptor. TiPS 6: 403?407","journal-title":"TiPS"},{"key":"CR23","volume-title":"Statistical principles in experimental design","author":"BJ Winer","year":"1971","unstructured":"Winer BJ (1971) Statistical principles in experimental design. McGraw-Hill, New York"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/cne.903510304","volume":"351","author":"DE Wright","year":"1995","unstructured":"Wright DE, Seroogy KB, Lundgren KH, Davis BM, Jennes L (1995) Comparative localization of serotonin1A, 1C, and2 receptor subtype mRNAs in the rat brain. J Comp Neurol 351: 357?373","journal-title":"J Comp Neurol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0091-3057(90)90234-9","volume":"35","author":"FD Yocca","year":"1990","unstructured":"Yocca FD, Wright RN, Margraf RR, Eison AS (1990) 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats. Pharmacol Biochem Behav 35: 251?254","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01291879.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01291879\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01291879","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T14:25:58Z","timestamp":1556634358000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01291879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6]]},"references-count":25,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[1997,6]]}},"alternative-id":["BF01291879"],"URL":"https:\/\/doi.org\/10.1007\/bf01291879","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,6]]}}}